We used caffeine, an inhibitor of ATM/ATR [35], which can block DNA damage response, to assess whether arenobufagin-triggered DNA damage caused the cell cycle arrest at the G2 phase in HCC cells. Here, ATR is linked to hepatocellular carcinoma.